Medical Center Hospital is partnering with the City of Odessa, Ector County, and the State of Texas through the Texas Division of Emergency Management to provide a Regeneron Infusion Center in Odessa on the MCH campus.
Regeneron Infusion Center to Open in Odessa on Medical Center Hospital Campus Monoclonal antibody therapy to be available to COVID-19 patients upon referral.
ODESSA, TEXAS – Medical Center Hospital is partnering with the City of Odessa, Ector County, and the State of Texas through the Texas Division of Emergency Management to provide a Regeneron Infusion Center in Odessa on the MCH campus. The Infusion Center will be at One Doctors Place, Suite 700 (500 N. Washington) and is scheduled to open on Friday, August 20 at 1 p.m.
Regeneron is two medications – casirivimab and imdevimab – that make up this particular monoclonal antibody therapy. Monoclonal antibodies are lab-made proteins that mimic the immune system’s ability to fight off harmful pathogens, such as viruses. This therapy is for patients who have tested positive for COVID-19 and are at risk for hospitalization. Not only can it help prevent hospitalization, but it can also ease the symptoms of COVID-19 sooner.
Once open, a provider can make a referral for patients to receive the monoclonal antibody therapy. The provider will need to confirm their patient is a candidate and would benefit from the therapy, then call (432) 640-2022 to make the appointment. There is also an email to send appropriate documentation at email@example.com. The infusion center will be open from 7 a.m. – 6 p.m. Monday through Saturday.
The therapy is free, and the entire process takes about 90 minutes. Once signed-in, the patient will be taken to their room for the therapy through an IV, which takes about 20-25 minutes. Once complete, the patient will simply wait another 60 minutes to make sure they don’t have any adverse reactions, before being able to leave. It is a one-time infusion the helps boost the patient’s immune system to fight off the virus.